| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 11/04/2004 | US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 11/04/2004 | CA2522946A1 Selective spirocyclic glucocorticoid receptor modulators |
| 11/03/2004 | EP1473295A1 Fused bicyclic pyrimidine derivatives |
| 11/03/2004 | EP1255759A4 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds |
| 11/03/2004 | EP1191028B1 Tricyclic compounds having spiro union |
| 11/03/2004 | EP1173177B1 Use of macrolide compounds for the treatment of dry eye |
| 11/03/2004 | CN1543467A Diazacycloalkanes as oxytocin agonists |
| 11/03/2004 | CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin |
| 11/03/2004 | CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 11/02/2004 | US6812228 Benzoxazines for use in the treatment of parkinson's disease |
| 11/02/2004 | CA2103454C Macrocyclic immunomodulators |
| 10/28/2004 | WO2004092131A1 Indole derivatives as ppar modulators |
| 10/28/2004 | WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 10/28/2004 | WO2004091504A2 Substituted quinobenzoxazine analogs |
| 10/28/2004 | WO2004072085A3 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations |
| 10/28/2004 | US20040215017 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214812 4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors |
| 10/28/2004 | CA2521810A1 Substituted quinobenzoxazine analogs |
| 10/27/2004 | EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
| 10/27/2004 | EP1470125A1 Aminopiperidine derivatives |
| 10/27/2004 | EP1470123A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, related compositions and methods |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
| 10/27/2004 | EP0866793B1 Nitroimidazole antibacterial compounds and methods of use thereof |
| 10/27/2004 | CN1541214A Novel compounds |
| 10/27/2004 | CN1539826A Precursor of Lisinopril compound and synthetic method |
| 10/27/2004 | CN1172673C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 10/26/2004 | US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof |
| 10/26/2004 | US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 10/26/2004 | US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects |
| 10/26/2004 | CA2127411C Tricyclic derivatives |
| 10/21/2004 | WO2004089958A2 Crystallization and purification of macrolides |
| 10/21/2004 | WO2004089936A1 Heteroarylsulfonanilide derivative and medicinal composition containing the same |
| 10/21/2004 | WO2004089312A2 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 10/21/2004 | WO2004069832A3 Antibacterial agents |
| 10/21/2004 | WO2004058144A3 Antibacterial agents |
| 10/21/2004 | US20040209940 potent antibacterial activity against various bacteria including drug-resistant strains |
| 10/21/2004 | US20040209911 Mixture containing rapamycin; absorption efficiency |
| 10/21/2004 | US20040209895 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases |
| 10/21/2004 | US20040209871 Fused bicyclic nitrogen-containing heterocycles |
| 10/21/2004 | CA2517833A1 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 10/20/2004 | EP1468274A1 Potassium fluoroionophore |
| 10/20/2004 | EP1468001A1 Process for the preparation of 2-or-9-oxa-3,7-diazabicyclo(3.3.1)nonanes from 2-aminomethyl-2,3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 10/20/2004 | EP1468000A1 Phenyl substituted heterocyclic compounds useful as herbicides |
| 10/20/2004 | EP1467978A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 10/20/2004 | EP1467758A2 Methods for preparing immunoconjugates |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | CN1538842A Atineoplastic combinations |
| 10/19/2004 | US6806266 Staurosporin derivatives |
| 10/14/2004 | WO2004087145A2 Antibacterial agents |
| 10/14/2004 | WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 10/14/2004 | WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors |
| 10/14/2004 | WO2004043367A3 Fused heterocyclic compounds and use thereof |
| 10/14/2004 | WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 10/14/2004 | US20040204369 Novel amide derivatives |
| 10/14/2004 | US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders |
| 10/14/2004 | CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta. |
| 10/14/2004 | CA2519954A1 Benzamide modulators of metabotropic glutamate receptors |
| 10/13/2004 | EP1381613B1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1170830C Prepn. of levo-ofloxacin |
| 10/07/2004 | WO2004085569A2 Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation |
| 10/07/2004 | WO2004085442A2 New calix arene compounds, their process of preparation and their use, particularly as enzymatic mimes |
| 10/07/2004 | WO2004085441A1 New calix arene compounds, their process of preparation and their use, particularly as enzymatic mimes |
| 10/07/2004 | WO2004072086A3 Antiparasitic terpene alkaloids |
| 10/07/2004 | WO2004007709A3 Production of polyketides |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine |
| 10/07/2004 | US20040198797 cyclization, condensation of arylmalonic acid diamine with hydrazine forming 3-hydroxy-4-aryl-5-oxopyrazoline |
| 10/07/2004 | US20040198762 Antibiotics used for inducing immunosupression and for prophylaxis of graft vs host disease, autoimmune diseases, inflammation, leukemia, lymphoma, tumors, fungal infections, cell proliferation; bioavailability; stability |
| 10/07/2004 | US20040198719 Antagonist of MCP-1 function, and compositions and methods of use thereof |
| 10/07/2004 | US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen |
| 10/06/2004 | EP1463733A2 Mitotic kinesin inhibitors |
| 10/06/2004 | EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1037892B1 Piperidine derivatives |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1534026A Condensed quinazoline derirative used as tyrosine kinase inhibitor |
| 10/05/2004 | US6800648 Schizophrenia, bipolar disorders, parkinson's disease; drug abruse |
| 10/05/2004 | US6800642 Antipsychotic aminomethyl derivatives of 7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta[a]naphthalene |
| 10/05/2004 | US6800637 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 10/05/2004 | CA2244698C Derivatives of camptothecin for use in treating cancer |
| 09/30/2004 | WO2004083215A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/30/2004 | WO2004082606A2 Fused pyrrole compounds |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
| 09/30/2004 | CA2517755A1 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/30/2004 | CA2517034A1 Fused pyrrole compounds |
| 09/29/2004 | EP1461342A1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1460997A2 Methods for the purification of levofloxacin |
| 09/29/2004 | EP1392700B1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | EP1000059B1 Tricyclic vasopressin agonists |